No Data
Earnings Preview: PDSB to Report Financial Results on November 14
$PDS Biotechnology(PDSB.US)$ is scheduled to release its financial results on November 14 ET. Earnings PreviewAnalysts estimate $PDS Biotechnology(PDSB.US)$ to post revenue of USD0 for 2024Q3, EPS
PDS Biotechnology Price Target Maintained With a $21.00/Share by HC Wainwright & Co.
Noble Financial Maintains PDS Biotechnology(PDSB.US) With Buy Rating, Maintains Target Price $17
PDS Biotechnology: Strategic Advancements and Clinical Progress Drive Buy Rating
PDS Biotechnology | 10-Q: Q3 2024 Earnings Report
12 Health Care Stocks Moving In Thursday's Pre-Market Session